FI128318B - Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures - Google Patents

Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures Download PDF

Info

Publication number
FI128318B
FI128318B FI20165897A FI20165897A FI128318B FI 128318 B FI128318 B FI 128318B FI 20165897 A FI20165897 A FI 20165897A FI 20165897 A FI20165897 A FI 20165897A FI 128318 B FI128318 B FI 128318B
Authority
FI
Finland
Prior art keywords
irradiation
cell culture
arctic bramble
bramble
cell cultures
Prior art date
Application number
FI20165897A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20165897L (en
FI20165897A (en
Inventor
Liisa Nohynek
Riitta Puupponen-Pimiä
Kirsi-Marja Oksman-Caldentey
Heiko Rischer
Original Assignee
Teknologian Tutkimuskeskus Vtt Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teknologian Tutkimuskeskus Vtt Oy filed Critical Teknologian Tutkimuskeskus Vtt Oy
Priority to FI20165897A priority Critical patent/FI128318B/en
Priority to KR1020197017925A priority patent/KR102646959B1/en
Priority to PCT/FI2017/050808 priority patent/WO2018096212A1/en
Priority to EP17873936.3A priority patent/EP3544411A4/en
Publication of FI20165897L publication Critical patent/FI20165897L/en
Publication of FI20165897A publication Critical patent/FI20165897A/en
Application granted granted Critical
Publication of FI128318B publication Critical patent/FI128318B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A01H4/005—Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H3/00—Processes for modifying phenotypes, e.g. symbiosis with bacteria
    • A01H3/02—Processes for modifying phenotypes, e.g. symbiosis with bacteria by controlling duration, wavelength, intensity, or periodicity of illumination
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A01H4/002—Culture media for tissue culture
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04—Plant cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a method for producing artic bramble cell culture, said method comprising two stages, where in the first stage arctic bramble callus line is cultured in a liquid medium comprising a medium used for plant cell and tissue culture, under day-night irradiation regime under normal light or under irradiation using LED light carried out as day-night irradiation or as constant irradiation, to obtain primary arctic bramble suspension cell culture, and in the second stage the primary arctic bramble suspension cell culture is up-scaled in at least two steps in the liquid medium; and irradiation with LED light is used in the first stage or in the second stage or in both stages.

Description

ARCTIC BRAMBLE (RUBUS ARCTIC US) CELL CULTURES, METHOD FOR PRODUCING ARCTIC BRAMBLE CELL CULTURES, COMPOSITIONS COMPRISING ARCTIC BRAMBLE CELL CULTURES AND USE OF ARCTIC BRAMBLE CELL CULTURES
FIELD OF THE INVENTION
The present invention relates to a method for producing artic bramble cell cultures. The invention relates further to arctic bramble cell cultures obtained by the method. The invention relates also to compositions comprising arctic bramble cell cultures, and to the use of the arctic bramble cell cultures in cosmetic, hygiene and personal care applications, in food, nutrition, nutraceuticals, pharmaceutical products, and for providing aroma, flavor and/or color to the products.
BACKGROUND OF THE INVENTION
Arctic bramble (Rubus arcticus) is a unique arctic berry with special chemical and flavor components, which are exploited by food and beverage industry. Arctic bramble is a rare aromatic berry species. It is rich in phenolic compounds, such as tannins and anthocyanins with known beneficial effects to the human health. However, the availability and quality of wild berry material is strongly affected by seasonal variations and by chemical and biological pollutants. The annual crop of both wild and cultivated berries is extremely low, particularly because these berries are very sensitive to climate changes and plant pathogenic microbes, and they are difficult to cultivate. Therefore, the availability of berry material for industry is insufficient.
The cosmetic industry uses various plant-derived fractions due to their bioactivities in cosmetic products. Many cosmetic companies are constantly looking for more advanced products for the markets, such as products containing plant cell cultures, for providing bioactive effects. Plant metabolites are typically very complex, and therefore their chemical synthesis may be difficult or even impossible.
Plant cells and tissue cultures have been recognized as potential options for replacing whole plants as sources of valuable industrial plant bio-chemicals. Undifferentiated plant cells are totipotent, containing the full complement of genetic information, and therefore have the capacity to develop into any organ of the plant.
Plant callus is a mass of somatic cells that undergo dedifferentiation to give rise to totipotent embryogenic cells, which temporarily gain the ability to proliferate and/or regenerate an embryo. Callus and plant stem cells are fundamentally different from each other, despite the fact, that callus exhibits some stem cell-like properties for a temporary period, and that it has been cultured for useful plant compounds as an alternative source of plant stem cell.
Callus is similar as plant stem cell in its ability to differentiate, but the two are different in their origin. While plant stem cell exists in the meristematic tissues of plant, callus is obtained as a temporary response to cure wound in somatic cell. Only plant stem cells embedded in meristems can divide and give rise to cells that differentiate while giving rise to new stem cells. Cultured callus-derived cells provide a cost-effective and sustainable source of important natural products.
Cloudberry cell cultures have been studied and methods for their production have been proposed. WO 2013/124540 Al discloses cosmetic compositions containing cloudberry cell culture preparation, where said compositions have antioxidant and anti-aging effect. It protects the skin from UV radiation effects and it has effect on the procollagen I synthesis of aged fibroblasts. In said method callus is first produced from sterile cuts of cloudberry plant. The material is maintained on a medium favoring continuous growth of the nondifferentiated cells. Selected callus is then chosen for suspension culture, which is stepwise scaled up to large scale cultivation in a bioreactor. The biomass is harvested, followed by washing with water and freeze-drying. The freeze-dried powder may be used as such in cosmetic compositions or the powder may be extracted with methanol or ethanol and filtered prior to use.
Despite the ongoing research and development in the field, there is a need for new sustainable and ecological approaches to provide valuable and unique cell cultures originating from arctic bramble.
SUMMARY OF THE INVENTION
Cell culture technology offers a sustainable approach for utilizing the biosynthetic capacity of arctic bramble plant to produce valuable phenolic metabolites. Even new compounds, which cannot be found in the natural plant and berries, can be produced utilizing modified biosynthetic pathways.
An object of the invention is to provide a method for producing arctic bramble cell cultures.
Another object of the invention is to provide a method for producing arctic bramble cell cultures, said method being suitable particularly for larger industrial scale.
Another object of the invention is to provide compositions comprising said arctic bramble cell cultures.
An object of the invention is to provide arctic bramble cell cultures.
Another object of the invention is to use of the obtained arctic bramble cell cultures in cosmetic, hygiene and personal care products, as well as for food, nutrition, nutraceuticals, pharmaceuticals and as food flavors and colorants.
The present invention generally concerns producing arctic bramble cell cultures having unique compositions, where cell cultures are illuminated with LED-lights favoring strong production of anthocyanins in the culture.
The method of the invention for producing arctic bramble cell culture comprises two stages, where in the first stage arctic bramble callus line is cultured in a liquid medium comprising a medium used for plant cell and tissue culture, under day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, to obtain primary arctic bramble suspension cell culture, and in the second stage the primary arctic bramble suspension cell culture is up-scaled in at least two steps in the liquid medium; and irradiation with LED lights is used in the first stage or in the second stage or in both stages.
The invention also relates to compositions comprising arctic bramble cell cultures obtained by the method, said arctic bramble cell cultures comprising one or more of anthocyanins, procyanidins, phenolic acids, vitamins and fatty acids, beneficial for human health.
The invention further relates to the use of said arctic bramble cell cultures in cosmetic compositions, hygiene and personal care products, as well as in foods, feeds, pet foods nutritional compositions, nutraceutical compositions, pharmaceutical compositions, for example for providing effects beneficial to the health, and as providing flavor, aroma and/or color to the products.
Characteristic features of the invention are presented in the appended claims.
DEFINITIONS
The term cell culture refers here to callus or cell suspension culture or hairy root originating from arctic bramble (Rubus arcticus) plant, where said plant includes berries,
20165897 prh 24-11-2016 seeds, flowers, roots, leaves and pieces of plant stem, one or more of hypocotyl, cotyledon, leaf section, stem section, root section of a seedling; stem section including a node or an internode, and a leaf section of a mature plant.
The term MS medium refers here to Murashige and Skoog medium having a pH of 5.8, widely used in the field of plant cell and tissue culture. The MS medium may be modified, where the MS medium is supplemented with additions of sucrose, plant growth regulators, also called plant growth hormones, the pH may be adjusted, and for obtaining solid medium agar or gelrite may be added.
LED light carried out as intermitting irradiation refers here to illumination/irradiation carried out in intermittent periods with LED light irradiation (light period) and without LED light irradiation (dark period), where the dark period may be from 1 to 23 hours and the light period may be from 1 to 23 hours. An example of intermitting irradiation comprises irradiation carried as day-night irradiation (16/8hours).
Normal light refers here to incandescent light having illumination/irradiation intensity of 50-300 lx.
BRIEF DESCRIPTION OF DRAWINGS
Figure 1 shows anthocyanin contents of arctic bramble cell cultures obtained with the method of the invention using the specified irradiation with LED lights and without it.
DETAILED DESCRIPTION OF THE INVENTION
Arctic bramble cell culture may be established from wild or cultured arctic bramble plant materials. Examples of such materials are wild arctic bramble plants. Said plants may be collected for example from the northern region in Finland.
Callus may be produced from sterile pieces of in vitro grown arctic bramble plants, generated from sterilized pieces of the plant, or alternatively from surface sterilized pieces 35 of arctic bramble plant materials.
The callus is grown in vitro at sterile conditions, and it is maintained on a medium favoring continuous growth of the non-differentiated cells. Different callus lines (cell cultures) may be separated based on callus color. Particularly suitably bright colored callus of uniform 40 quality is selected by sub-culturing.
Typically, at least six different intensely colored callus lines may be selected, stabilized and maintained.
At least one selected callus line is suitably chosen for suspension culture.
In the present invention, at least one selected arctic bramble callus line (such as intensely colored callus line) is suspension cultured. The suspension culture is up-scaled to produce the arctic bramble cell cultures in amounts suitable for large industrial scale.
The obtained cell culture is suitably cryo-preserved to provide a stable powdery product.
It was surprisingly found that using the suspension culture method of the invention arctic bramble cell cultures having several advantageous effects could be obtained effectively and consistently on a large industrial scale. The obtained arctic bramble cell cultures exhibit valuable bioactivities and other properties. The method is sustainable and continuously large amounts of the arctic bramble cell culture may be produced.
The phenolic profiles of the obtained arctic bramble cell cultures are unique and different compared to the arctic bramble berry fruit. High amounts of natural colorants, i.e. anthocyanins and other valuable phenolic compounds may be produced with the method, in significant amounts. The cell cultures also contain natural aromas, flavors and lipids with beneficial fatty acid composition, which are desired ingredients for example in cosmetic, nutraceutical, nutritional and hygiene preparations. The cell cultures can be generated around the year, on an industrial scale, with consistent quality and composition, which can be constantly monitored.
Arctic bramble plant material
The arctic bramble (Rubus arcticus) plant material refers here to berries, seeds, flowers, roots, leaves and pieces of plant stem of arctic bramble plant, including one or more of hypocotyl, cotyledon, leaf section, stem section, root section of a seedling; stem section including a node or an internode, and a leaf section of a mature plant. Said plant material may originate from wild plants or cultivated plants.
Formation of calli
Callus may be produced from sterile pieces of in vitro grown arctic bramble plants, generated from sterilized pieces of arctic bramble plant material, or alternatively from surface sterilized pieces of arctic bramble plant material. Preferably callus produced from sterile pieces of in vitro grown arctic bramble plants, generated from sterilized pieces of arctic bramble plant material is used. Calli formed on arctic bramble explants (cell callus of arctic bramble cells derived from arctic bramble plant) is obtained.
In the producing of callus the plant material is suitably cut into pieces. The pieces may have size of about 0.5 - 10 cm.
The pieces of the plant material are treated with at least one surface sterilizing solution, preferably with an ethanol solution followed by hypochlorite solution, to obtain surface sterilized pieces. The ethanol solution comprises suitably at least 50 % v/v, preferably at least 65 % v/v of ethanol in water. The hypochlorite solution comprises from 1 to 3 % by weight of hypochlorite in water. Suitably the surface sterilized pieces are rinsed with sterile water and dried.
The surface sterilized (sterile) pieces may be used for the formation of the calli, however preferably sterile pieces of in vitro grown arctic bramble plants are used for the formation of the calli.
In an embodiment, the surface sterilized pieces are transferred to a solid medium used for plant cell and tissue culture, without plant growth regulators, followed by incubating the pieces with the medium under sterile conditions, at the temperature of 20 - 28°C, under day-night illumination period under normal light (light-dark irradiation regime), for the time of 1 - 4 weeks, whereby roots and new leaves (in vitro grown arctic bramble plants) formed on the arctic bramble explants are obtained. Typically, the day-night photoperiod under normal light refers to 16:8 photoperiod with irradiation 30-60 pmol/m2s. Preferably the solid medium used for plant cell and tissue culture is MS medium, with added sucrose and agar. Typically, 3% w/vol sucrose is added and the medium is solidified with agar. Suitably the incubation is carried out in sealed sterile boxes. Preferably the temperature is in the range of 20 - 25°C. Suitably the incubation is carried out for 1 -3 weeks.
Sterile pieces of the in vitro grown arctic bramble plants, generated from sterilized pieces of the plant material, or pieces of surface sterilized plant material are incubated on a solid medium, suitably MS medium, without or alternatively with plant growth regulators (PGR) favoring development of undifferentiated plant material called callus.
The callus is grown in vitro at sterile conditions, and it is maintained on a medium favoring continuous growth of the non-differentiated cells, suitably MS medium. Different callus lines (cell cultures) may be separated based on callus color.
In an embodiment the sterile pieces of the in vitro grown arctic bramble plants, or the surface sterilized pieces of arctic bramble plant, are transferred to a solid medium used for plant cell and tissue culture, with plant growth regulators, followed by incubating the pieces with the medium, under sterile conditions, at the temperature of 20 - 28°C, under daynight (light-dark) irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, for the time of 1 - 8 weeks, at the pH in the range of 3 - 7, whereby callus formed on arctic bramble explants is obtained. Preferably LED light is used, particularly preferably intermitting irradiation with LED light.
The day-night (light-dark) irradiation regime with normal light refers typically to a photoperiod 16:8 with irradiation 30-60 pmol/m2s.
The LED light or lights as defined on page 11 of this specification are preferably used.
Preferably the temperature is 20 - 25°C.
Preferably the incubation time is 1 - 4 weeks.
Preferably the pH is in the range of 4 - 6, particularly preferably 4-5.
Preferably the medium is a modified MS medium, where sucrose, agar or gelrite and plant growth regulators are added and where the pH is adjusted into the range of 3-7, preferably of 4 - 6. Suitably said modified MS medium comprises 3 % w/v sucrose and 8 gL'l Bacto agar and plant growth regulators.
The plant growth regulators (PGRs, plant growth hormones) are selected from cytokines, auxins and combinations thereof. Suitably the cytokine is kinetin, and a suitable auxin is α-naphthaleneacetic acid (NAA). Suitably 0.46 μΜ kinetin and 5.37 μΜ NAA is used.
The calli formed on the arctic bramble explants are separated from the explants and transferred to a fresh solid medium, preferable same as used in the forming of callus, and sub-cultured regularly favoring soft productive biomass. Cultured plant cells are totipotent,
20165897 prh 24-11-2016 and when treated with PGRs the cells multiply continuously producing biomass consisting of identical cells.
Different callus lines are separated based on the color of the callus, for sub-culturing.
The sub-culturing is carried out suitably as follows. The calli formed on the arctic bramble explants are separated from the explant and transferred to fresh solid medium and maintained under day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, preferably LED light is used, particularly preferably intermitting irradiation with LED light. During each 15 sub-culturing the medium is replaced with fresh medium with pH adjustment to 3-7, preferably to 4-6, particularly preferably to 4-5. The separated callus is sub-cultured every 2-6 weeks, suitably by gentle division, for 2 to 8 months to obtain sub-cultured callus line. Any dark brown material is removed Preferably the solid medium is a modified MS medium, where sucrose, agar or gelrite and plant growth regulator(s) are added and where the pH 20 is adjusted into the range of 3-7, preferably of 4 - 6., Preferably at least one PGR selected from cytokine, auxins and combinations thereof is included in said medium. The temperature of 20 - 28°C, preferably 20-25°C is used. Sub-cultured callus lines are obtained.
The day-night (light-dark) irradiation regime with normal light refers typically to a photoperiod 16:8 with irradiation 30-60 pmol/m2s.
The LED light or lights as defined on page 11 of this specification are preferably used.
Method for producing arctic bramble cell cultures
The method of the invention for producing arctic bramble cell cultures is particularly suitable for larger industrial scale, providing arctic bramble plant cell culture of consistent quality in high amounts. Up-scaling of the primary arctic bramble suspension cell culture is realized by suspension culturing carried out in at least two steps.
The method of the invention for producing arctic bramble cell cultures comprises two stages, where the first stage comprises generation of primary arctic bramble suspension cell culture, where arctic bramble callus line is cultured in a liquid medium comprising a medium used for plant cell and tissue culture, under day-night irradiation under normal 40 light, or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, to obtain primary arctic bramble suspension cell culture, and in the
20165897 prh 24-11-2016 second stage the arctic bramble suspension cell culture is up-scaled in at least two steps, and irradiation with LED light is used in the first stage or in the second stage or in both stages.
In a preferable embodiment, the up-scaling comprises at least three steps.
In another preferable embodiment, the upscaling comprises at least four steps.
Preferably LED light is used, particularly preferably intermitting irradiation with LED light.
In a preferable embodiment LED light carried out as day-night irradiation is used. Daynight irradiation refers typically to a photoperiod of 16:8 respectively.
First stage: Generation of primary arctic bramble suspension cell culture
In the first stage of the method generation of primary arctic bramble suspension cell culture 20 is carried out.
The first stage of the method comprises generation of primary arctic bramble suspension cell culture, where arctic bramble callus line is cultured in a liquid medium comprising a medium used for plant cell and tissue culture, to generate inoculum for larger scale. For 25 carrying out the suspension culture at least one arctic bramble callus line is introduced in a liquid medium comprising a medium used for plant cell and tissue culture, and water, said liquid medium having a pH of 3-7, at the temperature of 20 - 28°C, under day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation preferably LED light is used, particularly 30 preferably intermitting irradiation with LED light. The suspension culture is initiated suitably with 0.1- 20 g of a selected arctic bramble callus line in 10-200 ml of the liquid medium.
The suspension culture is sub-cultured every 7-15 day intervals and stepwise up-scaled to 50-500 ml, preferably to 200-500 ml culture in a suitable vessel, such as an Erlenmeyer flask. Suitably more than one replicate suspensions are cultured in the flasks, preferably 35 at least two replicate suspensions. The sub-culturing is carried out in the liquid medium as defined below. Any visually detectable clumps are removed, preferably after 2-4 subculturing, to provide a homogeneous suspension by visual inspection. After 2-10, preferably after 4-8 sub-culturing, primary arctic bramble suspension cell culture is obtained as a finely divided and homogeneous suspension, when inspected visually. In an 40 embodiment, the cells may be harvested using methods known in the art, and suspended in the fresh medium to obtain a homogeneous suspension. The primary arctic bramble suspension cell culture (inoculum) is used in the second stage.
The water used in the method is selected from sterilized MQ-water, RO-water, and tap water, preferably high purity sterilized MQ-water or RO-water.
Any medium used for plant cell and tissue culture may be used in the method, preferably the medium used for plant cell and tissue culture is a modified MS medium. Said modified MS medium comprises sucrose, suitably 3 % w/v. Said modified MS medium comprises plant growth regulators selected from cytokines, auxins and combinations thereof. Suitably the cytokine is kinetin, and a suitable auxin is o-naphthaleneacetic acid (NAA). Suitably 0.46 μΜ kinetin and 5.37 μΜ NAA (a-naphthaleneacetic acid) is used. The pH of modified MS medium is adjusted into the range of 3-7, preferably of 4 - 6.
The day-night (light-dark) irradiation regime under normal light refers typically to a photoperiod 16:8 with irradiation 30-60 pmol/m2s.
Preferably the temperature is 22-25°C.
The first stage is suitably carried out in a vessel comprising glass or plastic allowing the irradiation pass through the walls of the vessel. Suitably glass flasks used in the art are selected, such as Erlenmeyer flasks etc., or alternatively plastic flasks or bags may be used, which allow passing of the irradiation to the mixture/suspension.
The LED light or lights as defined on page 11 of this specification are preferably used.
Second stage: Up-scaling of the primary arctic bramble suspension cell culture
The second stage of the method comprises up-scaling of the primary arctic bramble suspension cell culture (inoculum from the first stage), where the up-scaling is carried out in at least two steps.
In the first step, the inoculum obtained from the first stage is sub-cultured, suitably every 10+5 days, and up-scaled to a volume of not more than 1000 ml. Suitably a vessel of 2001000 ml is used, preferably of 200-500 ml containing about 30 to 80 ml of the primary arctic bramble suspension culture, using the same medium and temperature as in the first stage. During this first step the culture is exposed to no irradiation, or irradiated using daynight irradiation regime using normal light or using LED light carried out as intermitting irradiation or as constant irradiation, to yield cell culture from the first step. Preferably the cells are harvested using methods known in the art, and suspended in the fresh medium to provide an inoculum.
In the second step the inoculum from the first step is up-scaled to a volume of not more than 20 I and made up to with the fresh medium to obtain initial cell density of 10-50 g L’ x, preferably 25-40 g L’1. Suitably a bio-reactor having the volume of 1-20 L, preferably ΙΙΟ L is used. The suspension is grown in the bio-reactor for 7-15 days, with optionally from 1 to 3 additions of the fresh medium. Suitably cultivation conditions, where the temperature is 20-28°C, preferably 22-26°C are used. Suitably the dissolved oxygen (DO) is at least 10%, preferably at least 20 %. Agitation speed, depending on cultivation vessel, is in the range of 20 to 300 rpm. The pH is suitably uncontrolled. The aeration of 0.25 0.5 I min-1 may be used. A suspension cell culture from the second step is obtained. Preferably the same medium as in the first stage is used. During this second step the culture is irradiated using day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, preferably LED light is used. In an embodiment where the second stage comprises more than two steps, the second step may be carried out exposed to no irradiation.
The suspension cell culture from the second step may be obtained as the final product or alternatively it may be used as inoculum in a third step. The cells may also be harvested using methods known in the art using methods known in the art and the harvested cells may be suspended in the fresh medium to provide the inoculum.
The second stage may also comprise a third step. In the third step the inoculum from the second step is up-scaled to volume of not more than 70 I, made up to with the fresh medium to obtain initial cell density of 10-50 g L’1, preferably 25-40 g L’1, suitably using a bio-reactor having the volume of 10-70 L, preferably 10-50 L. The suspension is grown in the bio-reactor for 7-15 days, with optionally one addition of fresh medium. Suitably cultivation conditions, where the temperature is 20-28°C, preferably from 22 to 26°C, and dissolved oxygen (DO) at least 10%, preferably at least 20 % are used. The agitation speed, depending on cultivation vessel, is suitably in the range of 20 - 150 rpm. The pH is suitably uncontrolled. The aeration is preferably 0.3 - 2 I min-1· The pressure is suitably in the range 0.008 to 0.2 bar, depending on cultivation vessel. Preferably the same medium as in the first stage is used. During this third step the culture is irradiated using day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation, preferably LED light is used, particularly preferably intermitting irradiation with LED light. In an embodiment where the second stage comprises more than three steps, the third step may be carried out exposed to no irradiation.
A suspension cell culture from the third step is obtained as the final product or alternatively it may be used as inoculum in a fourth step. The cells may also be harvested using methods known in the art. The harvested cells may be suspended in the fresh medium to provide the inoculum.
The second stage may also comprise a fourth step. In the fourth steps the inoculum from the third step is up-scaled to volume of not more than 500 I made up to with fresh MS medium to obtain initial cell density of 10-50 g L’1, preferably 25-40 g L’1, suitably using a bio-reactor having the volume of 300-500 L. The suspension is grown in the bio-reactor for 7-15 days, with optionally one addition of fresh medium, which may comprise 2- to 4fold by weight of sucrose. Suitably cultivation conditions, where the temperature is from 20-28°C, preferably 22 to 26°C, and dissolved oxygen (DO) at least 10 %, preferably at least 20 % are used. The agitation speed is suitably in the range of 50 - 100 rpm. The pH is suitably uncontrolled. The aeration is 10-20 1 min-1. The pressure is preferably 0.2 bars. Preferably the same MS medium as in the first stage is used. During this fourth step the culture is irradiated using day-night irradiation regime under normal light or under irradiation using LED light carried out as intermitting irradiation or as constant irradiation preferably LED light is used, particularly preferably intermitting irradiation with LED light. A suspension cell culture comprising biomass is obtained. The cells may also be harvested using methods known in the art. The harvested cells may be suspended in the fresh medium.
The second stage may also comprise a further up-scaling steps.
In the method of the invention the final product suspension cell culture, comprising the biomass, obtained in the second stage, may be used as such, or alternatively it may be dried, suitably using cryo-drying or freeze-drying methods known in the art to provide a finely divided powder. Alternatively, the cells may also be harvested using methods known in the art, and used as such or dried.
The pH of the MS medium used in the method may preferably be adjusted to 3.5-5, in all steps before autoclaving the medium, using 0.1 M HCI.
The first step is suitably carried out in a vessel comprising glass or plastic allowing the irradiation pass through the walls of the vessel. Suitably glass flasks used in the art are selected.
The second and further up-scaling steps may be carried out in vessels, such as bioreactors allowing the cultivation to final culture volume and passing of the irradiation to the reaction mixture. Suitably vessels comprising glass or plastic material may be used.
LED light
LED (light emitting diode) light is used in the method. Preferably the LED light is used in all stages and all steps.
The LED light has color temperature of 2700-3000K.
In an embodiment, the LED light comprises an effectual spectrum comprising at least 25 % of an integral in the wave length range of 630 nm-760 nm (red light integral), calculated from the total effectual spectrum. Red light is generally classified as warm light shade.
In an embodiment, the LED light comprises a total effectual spectrum in the wave length range of 400-800nm.
In an embodiment, the LED light comprises less than 75 % of an integral in the wave length range of 400-450 nm (violet light integral) or of an integral in the wave length range of 450-490 nm (blue light integral) or of an integral in the wave length range of 490-560 nm (green light integral) or of an integral in the wave length range of 560-590 nm (orange light integral) or a combination thereof.
In the method irradiation source is preferably LED light with illumination intensity over 500 lx, preferable over 800 lx.
One LED light (source) or combination of LED lights (light sources) may be used.
Said LED lights may be arranged in a panel surrounding or enclosing the reaction vessel, or in any other way to provide the reaction mixture the required irradiation.
The final product suspension cell culture, comprising the biomass, obtained in the second stage, may be used as such in the manufacture of products, or alternatively it may be
20165897 prh 24-11-2016 dried, suitably using cryo-drying or freeze-drying methods known in the art to provide a finely divided powder.
Alternatively, the cells may also be harvested, and used as such or dried. The biomass may be separated using technique known in the art. Suitably a filter press or vacuum filtration 10 is used, where the biomass is filtered and washed with sterile water. The biomass filter cake is suitably dried, for example using freeze-drying. The dry biomass may be ground to finely divided powder and stored in sealed packages, preferably at temperatures of about -20°C.
Arctic bramble cell cultures are obtained.
Arctic bramble cell cultures
The arctic bramble cell cultures obtained with the method of the present invention exhibit high bioactivities and other beneficial and interesting properties.
The chemical composition of the cell cultures obtained by the method is clearly different from the one natural arctic bramble fruit. Using the irradiation with the specific LED light in the manufacturing method, high amounts of cell lines with very intense red, yellow, orange, green or purple color and unique chemical composition can be obtained in a 25 consistent manner.
Natural arctic bramble berry fruit contains typically hydroxycinnamic acids and their derivatives, anthocyanins, flavonols, ellagic acid derivatives and ellagitannins, gallic acid derivatives and cathechins. Procyanidins are not found in the natural plants. The arctic 30 bramble cell cultures obtained with the method may comprise 0.1-10 wt% (dry weight) of anthocyanins and 0.1-5 wt% (dry weight) of proanthocyanidins.
The arctic bramble cell cultures obtained by the method of the invention comprise surprisingly significant amounts of anthocyanins, and flavonoids, such as quercetin 35 derivatives, kaempherol derivatives, prodelphidins and procyanidins having high degree of polymerization, typically at least 13. Further, said arctic bramble cell cultures comprise typically about 200-400 mg/g of proteins, fatty acids such as α-linoleic acid and carbohydrates, such as sucrose.
Anthocyanins exhibit antioxidant and anti-inflammatory effect, in addition to intensive color, aroma and flavor, and thus they are beneficial for use in cosmetic, hygiene and
20165897 prh 24-11-2016 personal care applications, in food, feeds, pet foods, nutritional products, nutraceuticals, pharmaceutical products, and for providing aroma, flavor and/or color to the products.
. Antioxidant activity is also essential for example in delaying skin aging processes. With the method of the invention the anthocyanin content can be increased over seven-fold, particularly with the red-colored arctic bramble cell lines, compared to the manufacture 10 under normal light conditions, and further, the content other phenolic compounds is increased, especially the content of quercetin and procyanidin. The cells obtained with the method are more intact and contain significantly less water when compared with the ones manufactured under normal light conditions. They provide an advantage as being more effective and economic in downstream processing.
The phenolic compounds, such as flavonoids exhibit antimicrobial activity. Antimicrobial activity is beneficial in cosmetic applications, where for example in cosmetic products it helps to balance skin microbiota and prevents product contaminations.
The invention provides compositions comprising arctic bramble cell cultures obtained by the method, said arctic bramble cell cultures comprising anthocyanins, procyanidins, phenolic acids, vitamins and fatty acids beneficial for human health.
The invention relates also to compositions comprising arctic bramble cell cultures obtained 25 by the method of the invention, where the composition is selected from cosmetic compositions, hygiene and personal care products, as well as in foods, feeds, pet foods nutritional compositions, nutraceutical compositions, and pharmaceutical compositions.
The invention relates also to the use of said arctic bramble cell cultures in compositions 30 selected from cosmetic compositions, hygiene and personal care products, as well as in foods, feeds, pet foods nutritional compositions, nutraceutical compositions, and pharmaceutical compositions.
The cosmetic compositions may contain cosmetically acceptable substances in addition to 35 said arctic bramble cell culture(s). Said compositions may be used as day creams, foundation creams, peeling creams, lipsticks, color cosmetics, skin serums, mascaras, products for hair and/or scalp care, washing products for skin or hair, and as products for skin hygiene.
20165897 prh 24-11-2016
The cosmetic composition can be, for example, an emulsion cream, such as a day cream or a foundation cream; peeling cream; a lipstick; a skin serum or a hair cosmetics product, such as a composition for hair conditioning or a composition for scalp treatment.
The cosmetic composition may contain the arctic bramble cell culture in powder form in an 10 amount of 0.001 to 25 % by weight, more preferably the amount of the powder is 0.01 to % by weight, and most preferably 0.01-1 % by weight.
The emulsion cream containing arctic bramble cell culture can be of the type oil-in-water emulsion, water-in-oil emulsion, water-oil-water emulsion or a microemulsion. The 15 emulsion cream composition may contain the arctic bramble cell culture in powder form, preferably 0.001 to 25 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 1 % by weight.
In the emulsion creams the arctic bramble cell culture can be combined also with synthetic 20 or natural vitamins or their combinations. Examples of these vitamins are retinol and Avitamin palmitate. On the other hand, also different E-vitamins and E-vitamin derivatives, like tocopherol, C-vitamin and its derivatives, like ascorbyl palmitate and magnesium ascorbyl phosphate, panthenol and other B-vitamins and/or biotin may be used. The composition may contain synthetic and/ or natural vitamins preferably 0.01 to 10 % by 25 weight, more preferably 0.02 to 5 % by weight. The emulsion cream compositions may contain, in addition, one or more adjuvants acceptable in the field of cosmetics, such as preservation agents, thickening agents, moisturizing agents, and other suitable additives, such as for example perfumes and/or coloring agents. Suitable preservation agents are for example parabens, phenoxyethanol, imidazolidinyl urea and methyldibromo glutaronitrile.
These preservation agents can be used alone or combined with each other. Any thickening agent suitable in the field of cosmetics can be used provided, that it is compatible with the other components of the composition, for example xanthan gum and hydroxyethylcellulose, hydroxypropylmethylcellulose, Sclerotium gum, Chondrus Crispus, polyacrylates, polyacrylamides, cetearyl dimethicone crosspolymer and magnesium aluminium silicate. Thickening agents can be used alone or in combination with each other. Suitable moisturizing agents are for example heptyl undecylenate, hyaluronic acid or sodium PCA. In the emulsion creams, also different skin conditioning agents, for example tocopheryl acetate and ethylhexylglycerin may be used.
In addition, one or more compounds acting as an emulsifier, i.e. a compound dispersing and stabilizing the oil in water may be needed in the emulsion cream composition. Useful
20165897 prh 24-11-2016 emulsifiers are all non-ionic emulsifiers accepted by the cosmetic legislation, such as, for example, glyceryl stearate, PEG-5 glyceryl stearate, PEG-1 00 stearate, PEG-30 dipolyhydroxystearate, lecithin, hydrogenated lecithine and PEG- 8 bees wax, steareth-21, steareth-2, sorbitan olivate as well as a mixture of a fatty glucoside, such as for example cetearyl, cocoyl, or myristyl glucoside and a fatty alcohol, such as for example cetearyl, 10 cetyl, stearyl, octyldodecanol, caprylic/capric triglyceride or myristyl alcohol. In addition, of anionic emulsifiers, for example stearic acid, sodium hydroxide and triethanolamine are useful. Also, different chelating agents, like disodium EDTA and citric acid may be used.
The peeling cream compositions contain arctic bramble cell culture preferably 0.001 to 25 15 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 1 % by weight.
The peeling cream compositions may contain in addition to arctic bramble cell culture also other substances, which are acceptable in the field of cosmetics and which are traditional 20 components of peeling cream compositions. Peeling cream compositions can also contain emulsifiers like PEG-8, behenyl alcohol, arachidyl glucoside and arachidyl alcohol, thickening agents like ethylcellulose and various vitamins and derivatives of those, like tocopherol, ascorbyl palmitate and ascorbic acid.
The peeling cream compositions can in addition contain one or more adjuvants and/or additives acceptable in the field of cosmetics, such as preservation agent. Suitable preservation agents are for example parabens and phenoxyethanol. These preservation agents can be used alone or in combination with each other.
The lipstick compositions contain arctic bramble cell culture preferably 0.001 to 25 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 2 % by weight.
The lipstick compositions may contain in addition to arctic bramble cell culture also other substances, like different waxes, oils, coloring and pearlescent agents, which are 35 acceptable in the field of cosmetics and which are traditional components of lipstick compositions. Usable waxes are the natural waxes, such as bees wax, candelilla, carnauba, cereal based waxes, jojoba wax and their derivatives, in addition paraffin waxes and synthetic polyethylenes. Lipstick compositions can also contain emulsifiers like PEG-8, behenyl alcohol, arachidyl glucoside and arachidyl alcohol, thickening agents like 40 ethylcellulose and various vitamins and derivatives of those, like tocopherol, ascorbyl palmitate and ascorbic acid.
The lipstick compositions can in addition contain one or more adjuvants and/or additives acceptable in the field of cosmetics, such as preservation agent. Suitable preservation agents are for example parabens and phenoxyethanol. These preservation agents can be used alone or in combination with each other.
The compositions intended for hair or scalp care may contain arctic bramble cell culture, preferably 0.001 to 10 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 2 % by weight. Further, the compositions intended for hair or scalp care may also contain different caring agents. These caring agents are typically in the amount of 0.1 to 40 % by weight. Preferably the caring agent content of a product is 0.1 to 20 % by weight. The compositions intended for hair or scalp care may contain in addition to arctic bramble cell culture, also other substances acceptable in the field of cosmetics, like cationically active substances, such as cetrimonium chloride, in addition an emulsion forming substance, such as for example cetyl alcohol, cetearyl alcohol, ceteareth-20. In addition, the compositions intended for hair or scalp care can contain one or more adjuvants acceptable in the field of cosmetics, such as a cellulose derivative, ethanol and/or water. Also, oils, waxes and fatty alcohols can be present in the compositions, according to the invention, intended for hair or scalp care.
The serum compositions may contain arctic bramble cell culture preferably 0.001 to 25 % by weight, more preferably 0.01 to 5 % by weight and most preferably 0.01 to 2 % by weight.
The serum compositions may contain also other substances acceptable in the field of cosmetics such as emulsifying agents, chelating agents, solvents, preservatives, stabilizers together with substances affecting the skin permeability of the composition. These substances may be e.g. methylpropanediol, glycerin, phenoxyethanol, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, xanthan gum, propanediol, ammonium acryloyldimethyltaurate/VP copolymer, polyisobutene, disodium EDTA, lecithin, glucose, hydrogenated phosphatidylcholine, inulin lauryl carbamate, PEG-7, trimethylolpropane coconut ether, chondrus crispus, ethyl pyrrolidone, and cellulose gum. Additionally, the serum compositions may contain different moisturizing and skin conditioning agents such as heptyl undecylenate, ethyl hexylglycerin, caprylyl glycol, ethyl hexyl cocoate, peat extract and glycolipids.
As indicated, the arctic bramble cell culture is preferably used in the form of freeze-dried powder, and the amounts given above are calculated for said powder. However, in case methanol or ethanol extracts are used, it is within the expertise of a person skilled in the art to adapt the amounts correspondingly.
The phenolic profile of the arctic bramble cell cultures of the present invention is unique and different compared to the arctic bramble berry fruit, as said cell cultures may contain procyanidins, gallic acid derivatives, kampherol derivatives, quercetin derivatives, vitamin E (o-tocopherol), unique carbohydrate composition and unique fatty acid composition. Some of the culture lines produce high amounts of natural colorants, i.e. anthocyanins. The cell cultures also contain natural flavors and lipids with beneficial fatty acid composition, which are desired ingredients in cosmetic and hygiene preparations. The cell cultures can be generated around the year at different scales in consistent quality, which can be constantly monitored. It was surprisingly found that several advantageous effects may be achieved with the present invention.
Examples
The following examples are illustrative embodiments of the present invention, as described above, and they are not meant to limit the invention in any way.
Example 1
GENERATING ARCTIC BRAMBLE SUSPENSION CELL CULTURE
0.5-1 g of callus line obtained from arctic bramble plant material (in vitro grown arctic bramble plant), with red-color was transferred in 10-20 ml of liquid MS medium, pH 4.0 with 0.46 μΜ kinetin, 5.37 μΜ NAA (o-naphthaleneacetic acid) for initiation of suspension cultures. The suspended callus cells were cultivated at 23 - 25°C under day-night illumination regime (photoperiod 16:8 h, irradiation 40 pmol m'2s_1) in Erlenmayer shake flasks using a shaker at 90 - 120 rpm. The cultures were sub-cultured after 11 +/- 3 days by diluting cultures 1:3 with the fresh medium, and the clumps of the callus were removed. After 4-8 sub-culturing the cell lines in suspension were used as inoculum in bioreactor up-scaling.
Example 2
CULTIVATION OF ARCTIC BRAMBLE CELL CULTURE IN BIOREACTOR WITH/WITHOUT LED -ILLUMINATION
The inoculum was red-coloured arctic bramble suspension cell culture (KAS 341/15), obtained from arctic bramble plant material with a method consisting of formation of calli and generation of suspension cell culture by favouring dark red coloured calli, as described in example 1. Said arctic bramble suspension cell culture was used as inoculum in glass bioreactors under illumination of LED light panel with light intensity of 860 lx, colour temperature 2700-3000K, spectral range of 450-780 nm, with at least 25 % of the emission in the range of 630-760 nm (fermenter A). A reference study was conducted with normal light of 120 lx in pilot hall (fermenter B).
Inoculum in both fermenters A and B comprising of arctic bramble cells (KAS 341/15) was made up to with the fresh MS medium described in example 1, to obtain initial cell density of 30 g L’1, for bio-reactors A and B having the volume of 2 L. The suspensions were grown in the both bio-reactors for 9 days. The cultivation conditions were the following: temperature 25°C, dissolved oxygen (DO) over 20 %, agitation speed 100-300 rpm, pH was followed but not controlled, aeration with pressurized air 1.5 l/min, continuous expose to light (LED or normal). Sampling was carried out after 3 and 6 days, where the viability of the cells was tested with FDA (Fluorescein Diacetate) staining. After 9 days period the viability of the final culture was measured by FDA, and the cells were separated from the liquid medium on Miracloth filtration paper by vacuum Buchner filtration. The fresh weight (FW) of the cells was measured, and after freeze-drying of the cells the dry weight (DW) was obtained. In table 1 viability, cell color, FW (fresh weight) and DW (dry weight) are presented.
Table 1.
Culture age (days) Viability % (FDA staining) Culture and cell colour FW g/l DW g/l
A B A B A B A B
0 95 95 Light red; few cells with pink vacuole 30 30 nd
3 95 95 More red, <5% Light red, >3%
6 95 95 More red Light red -
9 95 95 Strong red Light red 189.8 226.4 12,54 12.28
A - with LED light panel
B - with pilot hall background light
Both cultures grew very well and the viability stayed at over 95%. However, the LED illumination increased significantly the intensity of red colour in the bioreactor during 9 d cultivation. The dry weight of the biomass yield was higher in the LED illuminated fermenter, which means that the cells cultivated in LED light were more intact, whereas the cells with less light had higher water content in the cells.
Anthocyanins and phenolic compounds were analysed in the dry biomass by UHPLC-DADMS/MS of both tests A and B. The results are presented in following table 2.
Table 2.
Detected compounds (mg/g) A B
Anthocyanins 5.8 0.8
Kamphferol derivatives 0.08 0.00
Quercetin derivatives 0.27 0.09
Procyanidins* 2.90 2.23
Prodelphidins 0.17 0.14
PC / PD ratio 94/6 94/6
* procyanidins have polymerization degree of 13.
Figure 1 shows anthocyanin contents (peak at about 3.1) of arctic bramble cell cultures obtained with LED irradiation (A) and without it (B).

Claims (13)

1. Menetelmä mesimarjan soluviljelmän tuottamiseksi, tunnettu siitä, että menetelmä käsittää kaksi vaihetta, missäA method for producing a honeydew cell culture, characterized in that the method comprises two steps, wherein 10 ensimmäisessä vaiheessa mesimarjan kalluslinjaa, joka on saatu in vitro kasvatettujen mesimarjakasvien steriileistä paloista tuotetusta kalluksesta, viljellään nestemäisessä elatusaineessa, joka käsittää kasvisolujen ja kudosten viljelyyn käytettävää elatusainetta, päivä-yö säteilytysohjelmalla normaalivalaistuksessa tai LED-valosäteilytyksessä käyttäen LED-valoaIn the first 10 stages, honeysuckle callus lines obtained from callus produced from sterile pieces of in vitro grown honeysuckle plants are cultured in a liquid medium comprising a culture medium for plant cells and tissues, with a day-night irradiation program under normal lighting or LED light irradiation using LED 15 jaksottaisena säteilytyksenä tai jatkuvana säteilytyksenä, jolloin saadaan primäärinen mesimarjasuspensiosoluviljelmä, toisessa vaiheessa primäärisen mesimarjasuspensiosoluviljelmän mittakaavaa suurennetaan vähintään kahdessa vaiheessa nestemäisessä elatusaineessa; ja LED-valosäteilytystä käytetään ensimmäisessä vaiheessa tai toisessa vaiheessa tai15 as intermittent irradiation or continuous irradiation to obtain a primary honeydew suspension cell culture, in a second step, the scale of the primary honeydew suspension cell culture is increased in at least two steps in a liquid medium; and the LED light irradiation is used in the first stage or the second stage or 20 molemmissa vaiheissa; ja jos toinen vaihe käsittää enemmän kuin kaksi vaihetta, toinen vaihe voidaan toteuttaa ilman säteilytystä.20 in both stages; and if the second step comprises more than two steps, the second step may be performed without irradiation. 2. Patenttivaatimuksen 1 mukainen menetelmä, tunnettu siitä, että toisessaA method according to claim 1, characterized in that in the second 25 vaiheessa primäärisen mesimarjasuspensiosoluviljelmän mittakaavaa suurennetaan vähintään kolmessa vaiheessa.In 25 steps, the scale of the primary honeydew suspension cell culture is increased in at least three steps. 3. Patenttivaatimuksen 1 tai 2 mukainen menetelmä, tunnettu siitä, että toisessa vaiheessa primäärisen mesimarjasuspensiosoluviljelmän mittakaavaaA method according to claim 1 or 2, characterized in that in the second step the scale of the primary honeydew suspension cell culture 30 suurennetaan vähintään neljässä vaiheessa.30 is magnified in at least four steps. 4. Jonkin patenttivaatimuksen 1-3 mukainen menetelmä, tunnettu siitä, että nestemäinen elatusaine on modifioitu MS elatusaine, joka käsittää vähintään yhtä komponenttia, joka valitaan sukroosin, agarin, gelriitin, kasvin kasvusäätäjien jaA method according to any one of claims 1 to 3, characterized in that the liquid medium is a modified MS medium comprising at least one component selected from sucrose, agar, gelite, plant growth regulators and 35 niiden yhdistelmien joukosta, ja modifioidun MS elatusaineen pH säädetään välille35 of these combinations, and the pH of the modified MS medium is adjusted to 3-7.3-7. 5. Patenttivaatimuksen 4 mukainen menetelmä, tunnettu siitä, että kasvin kasvunsäätäjä valitaan sytokiinien, auksiinien ja niiden yhdistelmien joukosta.A method according to claim 4, characterized in that the plant growth regulator is selected from cytokines, auxins and combinations thereof. 6. Jonkin patenttivaatimuksen 1-5 mukainen menetelmä, tunnettu siitä, että LEDvalon värilämpötila on alueella 2700-3000K.Method according to one of Claims 1 to 5, characterized in that the color temperature of the LED light is in the range from 2700 to 3000 K. 20165897 prh 25 -02- 202020165897 prh 25 -02- 2020 55 7. Jonkin patenttivaatimuksen 1-6 mukainen menetelmä, tunnettu siitä, että LEDvalo käsittää tehospektrin, joka käsittää vähintään 25 % aallonpituusalueen 630 nm-760 nm integraalia, laskettuna kokonaistehospektristä.Method according to one of Claims 1 to 6, characterized in that the LED light comprises a power spectrum comprising at least 25% of the integral of the wavelength range 630 nm to 760 nm, calculated from the total power spectrum. 8. Jonkin patenttivaatimuksen 1-7 mukainen menetelmä, tunnettu siitä, ettäMethod according to one of Claims 1 to 7, characterized in that 10 säteilytyslähde on LED-valo, jonka valon intensiteetti on enemmän 500 Ix, edullisesti enemmän kuin 800 Ix.The radiation source is an LED light having a light intensity of more than 500 Ix, preferably more than 800 Ix. 9. Jonkin patenttivaatimuksen 1-8 mukaisella menetelmällä saadut mesimarjasoluviljelmät, missä mainittu soluviljelmä käsittää 0,1-10 p-%Honeydew cell cultures obtained by a method according to any one of claims 1 to 8, wherein said cell culture comprises 0.1 to 10% by weight 15 (kuivapainosta) antosyaniineja ja 0,1-5 p-% (kuivapainosta) proantosyanidiineja.15 (dry weight) anthocyanins and 0.1-5 wt% (dry weight) proanthocyanidins. 10. Patenttivaatimuksen 9 mukaista soluviljelmää käsittävä koostumus, tunnettu siitä, että koostumus valitaan kosmeettisten koostumusten, hygienia- ja henkilökohtaisten hoitotuotteiden, elintarvikkeiden, rehujen, lemmikkiruokien,Composition comprising a cell culture according to claim 9, characterized in that the composition is selected from the group consisting of cosmetic compositions, hygiene and personal care products, foodstuffs, feedingstuffs, pet food, 20 täydennysravinne-koostumusten, ravitsemuksellisten koostumusten ja farmaseuttisten koostumusten joukosta.20 among supplemental nutrient compositions, nutritional compositions and pharmaceutical compositions. 11. Patenttivaatimuksen 10 mukainen koostumus, tunnettu siitä, että kosmeettinen koostumus valitaan päivävoiteiden, yövoiteiden, värivoiteiden, kuorintavoiteiden,Composition according to Claim 10, characterized in that the cosmetic composition is selected from day creams, night creams, color creams, exfoliating creams, 25 huulipuikkojen, värikosmetiikan, ihoseerumeiden, ripsivärien, hiusten ja päänahan hoitotuotteiden, ihon ja hiusteen pesuun tarkoitettujen tuotteiden, ja ihohygieniatuotteiden joukosta.25 among lipsticks, color cosmetics, skin serums, mascaras, hair and scalp care products, skin and hair washing products, and skin hygiene products. 3030 12. Patenttivaatimuksen 11 mukainen koostumus, tunnettu siitä, että kosmeettinen koostumus käsittää mesimarjasoluviljelmää jauheen 0.001 - 25 p-% määrässä, edullisemmin jauheen määrä on 0.01 - 5 p-%, ja edullisimmin 0.01-1 p-%.Composition according to Claim 11, characterized in that the cosmetic composition comprises a honeydew cell culture in an amount of 0.001 to 25% by weight of powder, more preferably 0.01 to 5% by weight of powder, and most preferably 0.01 to 1% by weight. 13. Patenttivaatimuksen 9 mukaisen mesimarjasoluviljelmän käyttö kosmeettisissaUse of a honeydew cell culture according to claim 9 in cosmetics 35 koostumuksissa, hygienia- ja henkilökohtaisissa hoitotuotteissa, elintarvikkeissa, rehuissa, lemmikkiruoissa, täydennysravinnekoostumuksissa, ravitsemuksellisissa koostumuksissa ja farmaseuttisissa koostumuksissapa antamaan aromeja, makua, ja/tai väriä tuotteille.35 in compositions, hygiene and personal care products, food, feed, pet food, supplemental nutritional compositions, nutritional compositions and pharmaceutical compositions to impart flavor, taste, and / or color to products.
FI20165897A 2016-11-24 2016-11-24 Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures FI128318B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI20165897A FI128318B (en) 2016-11-24 2016-11-24 Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures
KR1020197017925A KR102646959B1 (en) 2016-11-24 2017-11-22 Artichoke bramble (Rubus articus) cell culture, method of producing Artich bramble cell culture, composition comprising Artich bramble cell culture, and uses of Artique bramble cell culture
PCT/FI2017/050808 WO2018096212A1 (en) 2016-11-24 2017-11-22 Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures
EP17873936.3A EP3544411A4 (en) 2016-11-24 2017-11-22 Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20165897A FI128318B (en) 2016-11-24 2016-11-24 Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures

Publications (3)

Publication Number Publication Date
FI20165897L FI20165897L (en) 2018-05-25
FI20165897A FI20165897A (en) 2018-05-25
FI128318B true FI128318B (en) 2020-03-13

Family

ID=62195788

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20165897A FI128318B (en) 2016-11-24 2016-11-24 Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures

Country Status (4)

Country Link
EP (1) EP3544411A4 (en)
KR (1) KR102646959B1 (en)
FI (1) FI128318B (en)
WO (1) WO2018096212A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20175668A (en) * 2017-07-07 2019-01-08 Teknologian Tutkimuskeskus Vtt Oy Method for producing cell cultures of the family betulaceae, compositions comprising said cell cultures and use of said cell cultures
CN109496843A (en) * 2018-11-21 2019-03-22 内蒙古医科大学 A kind of sachalin raspberry leaf adventitious bud quick breeding method for tissue culture
CN110810241A (en) * 2019-11-22 2020-02-21 江苏东郁植物科技有限公司 Tissue culture seedling propagation method for raspberries

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3737417B2 (en) * 2001-01-19 2006-01-18 パク、キ−ヨエウ Method for mass growth of adventitious roots of ginseng, camphor ginseng, and ginseng by tissue culture and improvement of saponin content
JP5712672B2 (en) * 2010-02-09 2015-05-07 国立大学法人 宮崎大学 Blueberry cultivation method
GB201108519D0 (en) * 2011-05-20 2011-07-06 Naturally Scient Technologies Ltd Photosynthetic process

Also Published As

Publication number Publication date
KR20190089012A (en) 2019-07-29
KR102646959B1 (en) 2024-03-14
EP3544411A1 (en) 2019-10-02
WO2018096212A1 (en) 2018-05-31
EP3544411A4 (en) 2020-04-29
FI20165897L (en) 2018-05-25
FI20165897A (en) 2018-05-25

Similar Documents

Publication Publication Date Title
EP2260829B1 (en) Use of an extract from snow algae in cosmetic or dermatological formulations
Imchen et al. Marine algae colorants: Antioxidant, anti-diabetic properties and applications in food industry
FR3056907B1 (en) METHOD FOR PREVENTING OR SLOWING THE APPEARANCE OF INESTHETIC SIGNS GENERATED BY POLLUTANTS IN THE ATMOSPHERE ON SKIN, SCALP, HAIR OR MUCOSES
FI128318B (en) Arctic bramble (rubus arcticus) cell cultures, method for producing arctic bramble cell cultures, compositions comprising arctic bramble cell cultures and use of arctic bramble cell cultures
EP2914242B1 (en) Cosmetic compositions containing fractions of lingonberry extracts
Patel Reviewing the prospects of Opuntia pears as low cost functional foods
KR102354412B1 (en) Cosmetic Composition Comprising Lactobacillus Fermented product of Mixed Flower Extracts as Active Ingredient
EP2817070B1 (en) Cosmetic compositions containing cloudberry cell culture preparation
JP2021045127A (en) Method for mass production of carotenoids
WO2019008225A1 (en) Method for producing cell cultures of the family betulaceae, compositions comprising said cell cultures and use of said cell cultures
Toker Porphyridum Cruentum as a natural colorant in chewing gum
KR20120057370A (en) Anti-aging Composition Comprising Plant Stem Cell Derived from Cambium of Family Ginkgoaceae
ES2686502T3 (en) Use of bougainvillea plant cells for encapsulation of active ingredients
EP2441433B1 (en) Olleya marilimosa and its use in a method for the preparation of a composition comprising zeaxanthin
KR101694660B1 (en) Ultrasonicating extract of Perilla frutescens buds under darkroom condition with anti-inflamatory effect
KR101567325B1 (en) A functional compositoion comprising Chrysanthemum morifolium extract
CN111991276A (en) Moisturizing cream containing desert algae extract and preparation method
Calinoiu et al. Fruit and vegetable waste and by-products for pigments and color
KR20180137729A (en) Culture medium composition comprising mineral for improving production of spirulina and producing method thereof
KR101291460B1 (en) A Skin External Composition Containing Callus Extract Drived from Eleutherococcus koreanum Nakai
ALdeen et al. Saponins, glycosides and flavonoids in cells and tissues of balanites aegyptiaca cultured on solid and liquid culture media
EP3134100B1 (en) Cosmetic compositions for topical application comprising bougainvillea plant cells
Smith et al. Stimulation of bioactive flavonoid production in suspension and bioreactor-based cell cultures
Karahan et al. The alternative approaches to anthocyanin production by callus culture of Vaccinium arctostaphylos L. and the ultrastructure of anthocyanin-producing callus
JPH0987620A (en) Treated material of cotyledon and its production

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 128318

Country of ref document: FI

Kind code of ref document: B